针对感染性休克ICU患者非复苏性液体的优化限制性策略对液体平衡的影响:单盲、多中心、随机对照预试验
这项在法国3家医院ICU开展的多中心、随机、单盲、平行对照预试验纳入感染性休克且血管升压药输注24小时内的18-85岁患者,1:1随机分为优化限制性液体策略组(前7天尽可能减少维持液体和药物稀释用液体)与标准液体策略组,主要终点为前5天累积液体平衡(ml/kg)。2021年9月至2023年2月筛查1201例,纳入50例,对照组2例退出,最终分析48例(每组24例)。前5天限制性策略组与对照组分别接受89.7(IQR 35;128.9)与114.3(IQR 78.8;168.5)ml/kg液体(平均差异35.9 ml/kg [0.0;71.8],p=0.0506);第5天后中位累积液体平衡分别为6.9(IQR -13.7;52.1)与35.0(IQR -7.9;40.2)ml/kg(绝对差异13.2 [95%CI -15.2;41.6],p=0.42);28天死亡率与无生命支持存活天数两组相似。作者结论为优化限制性液体策略未降低第5天总体液体平衡。
要点
- 感染性休克血管升压药开始24小时内、18-85岁ICU患者中,优化限制性液体策略未降低第5天累积液体平衡(绝对差异13.2 ml/kg,95%CI -15.2~41.6,p=0.42)。
- 前5天限制性策略组与对照组分别接受89.7(IQR 35;128.9)与114.3(IQR 78.8;168.5)ml/kg液体,平均差异35.9 ml/kg(0.0;71.8),p=0.0506。
- 第5天后中位累积液体平衡限制性策略组6.9(IQR -13.7;52.1)ml/kg vs 对照组35.0(IQR -7.9;40.2)ml/kg,绝对差异13.2(95%CI -15.2;41.6),p=0.42。
- 28天死亡率与无生命支持存活天数两组相似。
- 严重高钠血症限制性策略组1例 vs 对照组2例;急性肾损伤KDIGO 3级限制性策略组4例 vs 对照组7例。
适用人群与场景
- 18-85岁、入住法国3家医院ICU、感染性休克且处于血管升压药输注最初24小时内的患者。
- 排除标准:需要肾脏替代治疗的急性肾损伤、终末期慢性肾脏病、严重营养不良。
处置流程与药物剂量
- 优化限制性液体策略:前7天尽可能减少维持液体和药物稀释用液体的入量。
- 对照为标准液体策略。
研究设计与关键结果
- 多中心、随机、单盲、平行、对照预试验;2021年9月至2023年2月筛查1201例,纳入50例,对照组2例退出,最终分析48例(每组24例)。
- 主要终点前5天累积液体平衡:限制性策略组89.7(IQR 35;128.9)ml/kg vs 对照组114.3(IQR 78.8;168.5)ml/kg,平均差异35.9 ml/kg(0.0;71.8),p=0.0506。
- 第5天后中位累积液体平衡:限制性策略组6.9(IQR -13.7;52.1)ml/kg vs 对照组35.0(IQR -7.9;40.2)ml/kg,绝对差异13.2(95%CI -15.2;41.6),p=0.42。
- 28天死亡率与无生命支持存活天数两组相似。
- 主要不良事件:严重高钠血症限制性策略组1例 vs 对照组2例;急性肾损伤KDIGO 3级限制性策略组4例 vs 对照组7例。
证据类型、等级与局限
- 研究类型:多中心、随机、单盲、平行、对照预试验。
- 患者与统计学家对分组设盲,临床医生未设盲。
- 试验注册:ClinicalTrials.gov标识NCT04947904,2021年7月1日注册。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:在感染性休克ICU患者中,以隐性液体入量为目标的优化限制性液体策略未降低第5天总体液体平衡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In septic shock, the classic fluid resuscitation strategy can lead to a potentially harmful positive fluid balance. This multicenter, randomized, single-blind, parallel, controlled pilot study assessed the effectiveness of a restrictive fluid strategy aiming to limit daily volume.
METHODS: Patients 18-85 years' old admitted to the ICU department of three French hospitals were eligible for inclusion if they had septic shock and were in the first 24 h of vasopressor infusion. Exclusion criteria were acute kidney injury requiring renal replacement therapy, end stage chronic kidney disease, and severe malnutrition. Patients were electronically randomized 1:1 to either an optimized fluid restriction (reducing fluid intake as much as possible in terms of maintenance fluids and fluids for drug dilution during the first 7 days) or standard fluid strategy. The primary outcome was cumulative fluid balance (ml/kg) in the first 5 days. Patients and statisticians were blinded to group arm, but not clinicians.
RESULTS: Between September 2021 and February 2023, 1201 patients were screened and 50 included, with two in the control group withdrawing, thus 48 patients were analyzed (24 in each group). In the first 5 days, the optimized restrictive strategy and control groups received 89.7 (IQR 35; 128.9) and 114.3 (IQR 78.8; 168.5) ml/kg of fluid, respectively (mean difference: 35.9 ml/kg [0.0; 71.8], p = 0.0506). After 5 days, the median cumulative fluid balance was 6.9 (IQR - 13.7; 52.1) and 35.0 (IQR - 7.9; 40.2) ml/kg in the optimized restrictive strategy and control groups, respectively (absolute difference 13.2 [95%CI - 15.2; 41.6], p = 0.42). After 28 days, mortality and the numbers of days alive without life support were similar between groups. The main adverse events were severe hypernatremia in 1 and 2 patients in the fluid restriction strategy and control groups, respectively, and acute kidney injury KDIGO 3 in 4 and 7 patients in the fluid restriction strategy and control groups, respectively.
CONCLUSIONS: In ICU patients with septic shock, an optimized restrictive fluid strategy targeting hidden fluid intakes did not reduce the overall fluid balance at day 5. Trial registration ClinicalTrials.gov identifier NCT04947904, registered on 1 July 2021.
参考来源
- Boulet N, Quenot JP, Serrand C, et al. Impact on fluid balance of an optimized restrictive strategy targeting non-resuscitative fluids in intensive care patients with septic shock: a single-blind, multicenter, randomized, controlled, pilot study. Crit Care. 2024. PMID: 39709493. doi:10.1186/s13054-024-05155-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。